<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9027">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05706831</url>
  </required_header>
  <id_info>
    <org_study_id>345</org_study_id>
    <nct_id>NCT05706831</nct_id>
  </id_info>
  <brief_title>Music Intervention and Transcranial Electrical Stimulation for Neurological Diseases</brief_title>
  <official_title>Music Intervention and Transcranial Electrical Stimulation for Treating Neurological Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istituti Clinici Scientifici Maugeri SpA</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Bari Aldo Moro</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Istituti Clinici Scientifici Maugeri SpA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this clinical trial is to evaluate the efficacy of a musical interventionand&#xD;
      non-invasive brain stimulation in neurological patients. The main questions it aims to answer&#xD;
      are:&#xD;
&#xD;
        -  to evaluate the residual neuroplastic processes in DOC state related to music exposure&#xD;
&#xD;
        -  to determine the putative modulation of the aforementioned processes and the clinical&#xD;
           outcome of DOC patients by non-pharmacological strategies, i.e., electric (tDCS) and&#xD;
           music stimulation&#xD;
&#xD;
        -  to evaluate the impact of this intervention on caregiver's burden and psychological&#xD;
           distress.&#xD;
&#xD;
      Participants will be randomly assigned to one of three different music-listening intervention&#xD;
      groups. Primary outcomes will be clinical, that is based on the neurologist's observations of&#xD;
      clinical improvement, and neurophysiological, collected pre-intervention, post-intervention&#xD;
      and post-placebo.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2022</start_date>
  <completion_date type="Anticipated">August 30, 2025</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Three groups of neurological patients will be considered for the study. For each group, participants will be randomly allocated to one of three intervention groups. These interventions will consist of a combination of musical stimulation, sham stimulation, tDCS and noise.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neuropsychological outcomes</measure>
    <time_frame>Change from baseline Coma Recovery Scale- Revised at 2 weeks and 4 weeks</time_frame>
    <description>-Coma Recovery Scale-Revised (CRS-R) - (0-23). High score means a better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological outcomes</measure>
    <time_frame>Change from baseline Disability Rating Scale at 2 weeks and 4 weeks</time_frame>
    <description>Disability Rating Scale (DRS) - (0-29). High score means a worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological outcomes</measure>
    <time_frame>Change from baseline Rancho Levels of Cognitive Functioning at 2 weeks and 4 weeks</time_frame>
    <description>Rancho Levels of Cognitive Functioning (LCF) - (1-8). High score means a better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological outcomes</measure>
    <time_frame>Change from baseline Glasgow Outcome Scale- Extended at 2 weeks and 4 weeks</time_frame>
    <description>Glasgow Outcome Scale- Extended (GOS-E) - (1-8). High score means a better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological outcomes</measure>
    <time_frame>Change from baseline Aachener Aphasie Test at 2 weeks and 4 weeks</time_frame>
    <description>Aachener Aphasie Test (AAT). This test includes six subtests: spontaneous speech, token test, repetition, written language, naming, and comprehension.&#xD;
Spontaneous speech is structured in six parts (0-30). High score means a better performance; Token test is composed by 50 items; for the score the number of error id considered (0-50).&#xD;
Repetition sub test is composed by 50 items; for each item the score range from 0 to 3; high score means better outcome (0-150).&#xD;
Written language subtest is composed by 30 items; for each item the score range from 0 to 3; high score means better outcome (0-90).&#xD;
Naming subtest is composed by 40 items; for each item the score range from 0 to 3; high score means better outcome (0-120).&#xD;
Comprehension subtest is composed by 40 items; for each item the score range from 0 to 3; high score means better outcome (0-120).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological outcomes</measure>
    <time_frame>Change from baseline Italian version of Functional Outcome Questionnaire for Aphasie at 2 weeks and 4 weeks</time_frame>
    <description>Italian version of Functional Outcome Questionnaire for Aphasie (FOQ-A) - (32-160). High score means a better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological outcomes</measure>
    <time_frame>Change from baseline Functional Assessment Measure - Cognitive subscale at 2 weeks and 4 weeks</time_frame>
    <description>Functional Assessment Measure - Cognitive subscale - (FAM) - (14-98); high score means a better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological outcomes</measure>
    <time_frame>Change from baseline Quality of Life Questionnaire for aphasics at 2 weeks and 4 weeks</time_frame>
    <description>Quality of Life questionnaire for Aphasics (QLQA) - (0-148); High score means a better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological outcomes</measure>
    <time_frame>Change from baseline The semi-structured scale for functional evaluation of personal neglect at 2 weeks and 4 weeks</time_frame>
    <description>The semi-structured scale for functional evaluation of personal neglect - (0-9); High score means a worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological outcomes</measure>
    <time_frame>Change from baseline Barrage Test at 2 weeks and 4 weeks</time_frame>
    <description>Barrage test (0-36). High score means a better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological outcomes</measure>
    <time_frame>Change from baseline Letter cancellation test at 2 weeks and 4 weeks</time_frame>
    <description>Letter cancellation test - (0-104). High score means a better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological outcomes</measure>
    <time_frame>Change from baseline Sentence reading test at 2 weeks and 4 weeks</time_frame>
    <description>Sentence reading test (0-6). High score means a worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological outcomes</measure>
    <time_frame>Change from baseline Wundt-Jastrow area illusion test at 2 weeks and 4 weeks</time_frame>
    <description>Wundt-Jastrow area illusion test (0-20). High score means a worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neuropsychological outcomes</measure>
    <time_frame>Change from baseline The semi structured scale for the functional evaluation of extrapersonal neglect at 2 weeks and 4 weeks</time_frame>
    <description>The semi structured scale for the functional evaluation of extrapersonal neglect (0-9). High score means a worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neurophysiological outcome</measure>
    <time_frame>Change from baseline oscillation at 2 weeks and 4 weeks</time_frame>
    <description>The ratio of fast (8-30 Hz, α-β) to slow (2-8 Hz, δ-θ) oscillation amplitude at the midline electrodes (Fz, Cz, Pz, Oz) will be measured and compared pre- and post intervention.&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Caregiver psychological distress</measure>
    <time_frame>Change from baseline Back depression Inventory II at 2 weeks and 4 weeks</time_frame>
    <description>Back depression Inventory II (BDI II) - (0-63). High score means a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Caregiver psychological distress</measure>
    <time_frame>Change from baseline State-trait anxiety inventory; at 2 weeks and 4 weeks</time_frame>
    <description>State-trait anxiety inventory (STAI-Y). It is composed by two scales: STAI-Y State (20-80) and STAI-Y Trait (20-80). High score means a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Caregiver psychological distress</measure>
    <time_frame>Change from baseline Questionario psicofisiologico (CBA) at 2 weeks and 4 weeks</time_frame>
    <description>Psychophysiological Questionnaire (30-120). WHOQOL-BREF.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Caregiver psychological distress</measure>
    <time_frame>Change from baseline Prolonged grief disorder -12 at 2 weeks and 4 weeks</time_frame>
    <description>Prolonged grief disorder -12 (PG-12) - (11-55). High score means a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Caregiver psychological distress</measure>
    <time_frame>Change from baseline Family strain questionnaire at 2 weeks and 4 weeks</time_frame>
    <description>Family strain questionnaire (FSQ) - (1-44). High score means a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Caregiver psychological distress</measure>
    <time_frame>Change from baseline Wolrd health organization - quality of life at 2 weeks and 4 weeks</time_frame>
    <description>better outcome.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Disorder of Consciousness</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group 1 will receive tEs combined with music stimulation for 2 weeks, 1 week of wash out, then sham stimulation combined with noise (placebo) for other 2 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group 2 will receive sham stimulation and noise (placebo) for the first 2 weeks, then 1 week wash out, and finally tEs and music stimulation for other 2 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group 3 will receive only music stimulation and sham stimulation for 2 weeks, 1 week of wash out, then sham stimulation and noise (placebo) for another 2 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Combinatory effect of music stimulation and neurostimulation</intervention_name>
    <description>music</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Post-stroke aphasia&#xD;
&#xD;
          -  Post-stroke neglect&#xD;
&#xD;
          -  Patients with disorders of consciusness (DOC)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No auditory injury&#xD;
&#xD;
          -  no hystory of neurological disease&#xD;
&#xD;
          -  No hystory of psychiatric disease&#xD;
&#xD;
          -  Previous stroke&#xD;
&#xD;
          -  use of alcohol and drugs&#xD;
&#xD;
          -  premorbid dementia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Simona Spaccavento</last_name>
    <phone>+393332783524</phone>
    <email>simona.spaccavento@icsmaugeri.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Istituti Clinici Scientifici Maugeri</name>
      <address>
        <city>Bari</city>
        <state>Ba</state>
        <zip>70025</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simona Spaccavento</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>November 16, 2022</study_first_submitted>
  <study_first_submitted_qc>January 30, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2023</study_first_posted>
  <last_update_submitted>January 30, 2023</last_update_submitted>
  <last_update_submitted_qc>January 30, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 31, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istituti Clinici Scientifici Maugeri SpA</investigator_affiliation>
    <investigator_full_name>Simona Spaccavento</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>music stimulation</keyword>
  <keyword>tDCS</keyword>
  <keyword>Aphasia</keyword>
  <keyword>Neglect</keyword>
  <keyword>DOC</keyword>
  <keyword>Stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Consciousness Disorders</mesh_term>
    <mesh_term>Nervous System Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

